Bone marrow is the soft spongy tissue that lies within the hollow interior of long bones. In adults, marrow in large bones produces new blood cells. Bone marrow forms around 4% of total body weight. There are two types of bone marrow: red marrow that is responsible fo... Readmore
Aim of the Journal
International Journal of Bone Marrow Research aims to publish valuable researches encompassing all aspects of bone marrow research that can assist in making bone marrow, stem cell or cord blood transplant an overwhelming experience for the patients and the doctors.
The manuscripts published in International Journal of Bone Marrow Research also seek to focus on the vital role of bone marrow in understanding blood and autoimmune diseases and in evaluating treatment options for patients.
Subscribe to our Article Alerts
There is a precept- "two heads result in more fruitful thing than one head alone". Heighten Science Publication unique concept of membership is based on this precept. Readmore
Heighten Science Publication (Heighpubs) works with the vision that a published work should be visualized by more and more people for their intellectual benefits. Readmore
Heighten Science Publication Corporation uses Double-Blind Peer Review policy for all the journals. Under this policy both the reviewers and authors identities are concealed... Readmore
Why with Us
Heighten Science has a rich history and track-record of delivering simpler and updated access to the research needs in disciplines of health, science, management and law. Readmore
to find colleagues at
Heighten Science Publications
We publish a wide range of article types in the Clinical, Medical, Biology, Engineering, Chemistry and Pharma.
2019-11-05 Review Article
Das Sanjita* and Kumar Naveen
The purpose of this study is to highlight the drug abuse hazards and preventive aspects. From a public health perspective, substance abuse has long been a source of major concern, both for the individual’s health and for wider society as a whole. The UK has the highest rates of recorded ...
2019-08-16 Letter to the Editor
Yvonne A Efebera*, Amy S Ruppert, Apollinaire Ngankeu, Sabrina Garman, Prasanthi Kumchala, Alan Howard, Steven M Devine, Parvathi Ranganathan and Ramiro Garzon
Allogeneic hematopoietic stem cell transplant (alloHSCT) is a curative treatment for many hematologic malignancies. Unfortunately, about 30-50% of all recipients undergoing alloHSCT develop acute graft-versus-host-disease (aGVHD), which is associated with high morbidity and mortality [1,...
2019-06-21 Research Article
Jan Jacques Michiels, Yonggoo Kim, Myungshin Kim, Francisca Valster, Vincent Potters, Zwi Berneman, Alain Gadisseur, Wilfried Schroyens and Hendrik De Raeve
The clinical phenotypes in 268 JAK2V617F mutated MPN patients in the Seoul study were PV in 101, ET in 95 and MF in 78 and 56 CALR mutated MPN consisted of PV in none, ET in 40 and MF in 16 cases. CALR mutated MPN patients were younger than JAK2V617F mutated MPN patients (mean ages 57.5 and 66...
2019-05-13 Case Report
The research concerning a preventive treatment of an osteoporitic femoral neck fracture started in 1990 because the surgical procedure of unstable femoral neck fractures is difficult. After effects are frequent and their number will increase in the next decade. The goal is to reinforce the fem...
2019-04-17 Research Article
Jan Jacques Michiels* and Hendrik De Raeve
The present article extends the PVSG-WHO criteria into a simplified set of Rotterdam and European Clinical, Molecular and Pathological (RCP/ECMP) criteria to diagnose and classify the myeloproliferative neoplasms (MPNs). The crude WHO criteria still miss the masked and early stages of ET and P...
2019-04-15 Research Article
Jan Jacques Michiels* and Hendrik De Raeve
Primary myelofibrosis (PMF) is a distinct clinicopathological myeloproliferatve disease (MPD) not preceded by any other MPD ET, PV, CML,... Combined use of bone marrow histology and increased erythrocyte counts above 5.8x1012/L can replace increased red cell mass at time of presentation as the...
2019-03-01 Research Article
Jan Jacques Michiels*, Zwi Berneman, Wilfried Schroyens, Fibo W J ten Kate, King Lam and Hendrik De Raeve
The broad spectrum of heterozygous versus homozygous JAK2V617F mutated MPN consists ET, ET with early features of PV (prodromal PV), classical PV, masked PV, advanced PV and post-PV myelofibrosis. Combined use of bone marrow histology and increased erythrocyte counts above 5.8x1012/L can repla...
2017-07-11 Research Article
Fauzia Shafi Khan*, Khalid Mahmood and Alia Ahmad
Pure Erythroid Leukemia (PEL) is an aggressive and exceedingly rare form of acute leukemia. In the 2008 WHO classification PEL was one of the subtypes of acute erythroid leukemia the other subtype being erythroleukemia (erythroid/ myeloid). In the 2016 WHO classification update, erythroleukemi...